Live Breaking News & Updates on Janssenus Janssen Scientific Affairs

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Marcp Bonaca , Marc Bonaca , Janssen Scientific Affairs , Janssen Pharmaceuticals Inc , Exchange Commission , Drug Administration , Janssenus Janssen Scientific Affairs , Division Of Cardiovascular Medicine , None Of Janssen Scientific Affairs , Department Of Medicine , Companies Of Johnson , Janssen Pharmaceutical Companies Of Johnson , American Heart Association , University Of Colorado Anschutz Medical Campus , Janssen Pharmaceutical Companies , Cardiovascular Medicine , Colorado Anschutz Medical Campus , Total Vascular Events , Fragile Patients , Plus Aspirin , Myocardial Infarction , Lower Extremity Revascularization , Vice President , Medical Affairs , Janssen Pharmaceuticals ,